Episode Details

Back to Episodes

Bonus Episode: Afni Shah-Hamilton - Podiatry and Oncology

Published 2 years, 5 months ago
Description

**Trigger Warning**

Naman Julka-Anderson and Jo McNamara catch up with Afni Shah-Hamilton.


Discussion about podiatry, supporting people living with and beyond cancer, and Afni’s future plans.

 

To use this podcast as CPD, look at these reflection points: 

1) read about the role of podiatrists in cancer care https://tiptoefootcare.com/wp-content/uploads/2021/04/Podiatrist-and-Cancer-care-Afni-1.pdf 

2) read about the neurological effects of systemic anti-cancer treatment on feet: https://tiptoefootcare.com/wp-content/uploads/2021/05/IOCP-anti-cancer-treatment-2-Afni-1.pdf 

3) read about the dermatological effects of systemic anti-cancer treatment on feet: https://tiptoefootcare.com/wp-content/uploads/2021/10/IOCP-Pod-Review-June21-art.2b.pdf 

4) read about rehab post-surgery for feet: https://tiptoefootcare.com/wp-content/uploads/2021/10/AFNI-CANCER-CARE-PART-4.pdf 


Complete this form for your accredited digital badge: https://bit.ly/3GbtR1X.


Links from podcast:

Tip Toe Foot Care: https://tiptoefootcare.com/foot-care-for-cancer-patients/

Afni’s publications: https://tiptoefootcare.com/publications/

Afni’s Webinars: https://tiptoefootcare.com/talks/


Afni Social Media:

https://www.facebook.com/Tiptoefootcare.Afni  

https://twitter.com/tiptoefootcare 


Please like and subscribe to Rad Chat on your podcast library.


Our links:

Link Tree: https://linktr.ee/radchat 

Facebook: https://www.facebook.com/RadChatPodcast/ 

Instagram: https://www.instagram.com/rad__chat/ 

LinkedIn: https://uk.linkedin.com/company/radtalk 

Tik Tok: https://www.tiktok.com/@rad_chat 

Twitter: https://twitter.com/rad__chat?lang=en 

© Rad Chat 2025. All rights reserved.  

We (or our licensors) own all intellectual property rights in this podcast and all related content, online and offline.  

You may not use, copy, modify, download, archive, reproduce, distribute, display, publish, licence, create derivative works from or commercially exploit any part of our content unless we expressly agree in writing.  

You must not use any images, audio, video, graphics or clips separately from their accompanying context.  

Please acknowledge Rad Chat (and any identified contributors) clearly whenever referencing or sharing our content.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us